FDA Investigator: Krystal O. Ogunremi
- Krystal O. Ogunremi first started conducting FDA inspections in 2008, with the last inspection in 2013. Over that time, Krystal O. Ogunremi has conducted 62 inspections at 57 companies across 60 sites.
Get Krystal Ogunremi's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Newark Beth Israel Med Ctr IRB, Newark | 2013
Out-of-stock
Krystal O. Ogunremi
Human Drug Form 483
FDA 483 Nelson Rassi, M.D., Principal Investigator, Goiana | 2013
Out-of-stock
Krystal O. Ogunremi
Human Drug Form 483
FDA 483 Nelson Rassi, M.D., Principal Investigator, Goiana | 2013
Out-of-stock
Krystal O. Ogunremi
Human Drug Form 483
FDA 483 Dr. Johnny Mahlangu, Principal Investigator, Johannesburg | 2013
Out-of-stock
Krystal O. Ogunremi
Biologic Form 483
FDA 483 Dr. Johnny Mahlangu, Principal Investigator, Johannesburg | 2013
Out-of-stock
Krystal O. Ogunremi
Biologic Form 483
FDA 483 Gromex Inc., Passaic | 2013
Out-of-stock
Krystal O. Ogunremi
Foods & Cosmetic Form 483
FDA 483 VA New Jersey Health Care System IRB, East Orange | 2013
Out-of-stock
Krystal O. Ogunremi
Human Drug Form 483
FDA 483 St Michael's Medical Center IRB, Newark | 2013
Out-of-stock
Krystal O. Ogunremi
Human Drug Form 483
FDA 483 Gregory T. Simonian, MD, Hackensack | 2012
Out-of-stock
Krystal O. Ogunremi
Medical Devices & Rad Health Form 483
FDA 483 Shionogi Inc., Florham Park | 2012
Out-of-stock
Krystal O. Ogunremi
Human Drug Form 483
FDA 483 Celgene Corporation, Berkeley Heights | 2012
Out-of-stock
Krystal O. Ogunremi
Human Drug Form 483
FDA 483 David S. Siegel, M.D., Hackensack | 2012
Out-of-stock
Krystal O. Ogunremi
Human Drug Form 483
FDA 483 David J. Goldberg, MD, Hillsborough | 2012
Out-of-stock
Krystal O. Ogunremi
Medical Devices & Rad Health Form 483
FDA 483 Peter S. Hersh, M.D., Teaneck | 2012
Out-of-stock
Krystal O. Ogunremi
Medical Devices & Rad Health Form 483
Co-Investigators (21)
- Cary Greene, FDA Investigator
- Jonee J. Mearns, FDA Investigator
- Valerie C. Reed, FDA Investigator
- Peter R. Lenahan, FDA Investigator
- Christina N. Maurino, FDA Investigator
- Michael Serrano, FDA Investigator
- David H. Smith, FDA Investigator
- Barbara J. Wilimczyk-Macri, FDA Investigator
- Melissa B. Libby, FDA Investigator
- Sherri J. Liu, FDA Investigator
- Alberto A. Viciedo, FDA Investigator
- Laishan L. Lam, FDA Investigator
- Liatte Krueger, FDA Investigator
- Gianine E. Tompkins, FDA Investigator
- Kelly Doremus, FDA Investigator
- Li Li, FDA Investigator
- Karen E. Dorazio, FDA Investigator
- Eric J. Cunningham, FDA Investigator
- Tressa T. Lewis, FDA Investigator
- Deborah B. Nixon, FDA Investigator
- Lawrence R. Johnson, FDA Investigator